Study explores the rate of insect consumption in Hungary over the five years between 2016 and 2021.
Jim Momtazee’s Patient Square leads $150M+ addition to Kriya Therapeutics’ ‘mainstream’ gene therapy ambitions
Shankar Ramaswamy’s Kriya Therapeutics has upped its Series C with an additional $150 million-plus to take the biotech into late 2026. The AAV-focused gene therapy